Union Minister reviews Power Sector and Urban Development Schemes with Jharkhand Govt (See 'Corp Brief') APEDA facilitates First Export of fresh Uttarakhand Litchi to Italy (See 'Corp Brief') Nadda calls for Push towards a TB-Free India (See 'Corp Brief') India must take control of security-related necessities to remain future-ready: RM (See 'Corp Brief') Nearly 25 Crore People moved out of poverty: Dr Jitendra Singh (See 'Corp Brief') Flagship Schemes and Innovative Interventions accelerate India's Clean Energy Transition (See 'Corp Brief') Tech Innovation and disruption in Construction Industry (See 'CORP EINSICHT') Historic Qadian-Beas Railway Line Project revived after Nearly 100 Years: Bittu (See 'Corp Brief') TEC workshop focuses on Spectrum Utilization and Satellite-Enabled 5G/6G Networks (See 'Corp Brief') Trade Marks - Quasi-judicial authority cannot validly base its decision on grounds that were not specifically disclosed in SCN, thereby depriving noticee of an effective opportunity to respond: HC (See 'Legal Desk') Smart Seed Technology delivers up to 30% Higher Yields in Groundnut and Soybean (See 'Corp Brief') Joshi launches Smart Warehousing System for Foodgrain Storage (See 'Corp Brief') NIXI to showcase India's growing Internet Ecosystem (See 'Corp Brief') A&C - Financial hardship cannot justify payment of disputed amount linked to fulfilment of deliverable-based obligations: HC (See 'Legal Desk') On Patna visit, Chouhan gives inspiring message in cleanliness campaign (See 'Corp Brief') Railways approves Rs 405 Crore Signalling Modernisation Project on Eastern Railway (See 'Corp Brief') Ministry of Coal to organize 3rd Roadshow on Surface Coal Gasification Projects in Mumbai (See 'Corp Brief') Bharat Innovates 2026 strengthens India's Position as Global Deep-Tech and Innovation Hub (See 'Corp Brief') DAE Secy & Chairman visit Tarapur site; commends NPCIL dedication to the Nuclear Energy Mission (See 'Corp Brief') Two-day Conference on Capacity Building and Strategic Roadmap concludes (See 'Corp Brief') IPR - Interim arrangement directing payment of ad hoc licence fees to copyright owner can continue upon determining that such entity cannot grant licences without registration u/s 33: HC (See 'Legal Desk') 'VB-G RAM G' national launch to begin from AP on July 1: Chouhan (See 'Corp Brief') Iconic Bridges: Pillars of New India's Infrastructure Transformation (See 'Corp Brief') 250 cyclists to join Union Sports Minister as Fit India Movement links cycling, yoga and healthy living (See 'Corp Brief') CCI okays TVS Emerald to acquire shares of combination of PGIM India Asset & PGIM India Trustees (See 'Corp Brief') IPR - Search engine cannot be permitted to auction or monetise that asset without proprietor's authorisation: HC (See 'Legal Desk') CCI approves subscription of equity by Kedaara Pearl & Kedaara Capital in Axis Finance (See 'Corp Brief') CCI nod for combination of certain CCPS and Romsons Group (See 'Corp Brief') PMLA - 180-day limit for provisional attachment cannot be extended due to Supreme Court's COVID limitation orders: HC (See 'Legal Desk')

Print

MoS reaffirms India's commitment to global pharmaceutical standardization

Published: Feb 06, 2025

By TIOLCorplaws News Service

NEW DELHI, FEB 06, 2025: UNION Minister of State for Health and Family Welfare, Anupriya Patel delivered the keynote address at the 15th International Meeting of World Pharmacopoeias (IMWP), hosted by the Indian Pharmacopoeia Commission (IPC) under the aegis of the Ministry of Health and Family Welfare, Government of India, in collaboration with the World Health Organization (WHO), here today. The meeting brought together global pharmacopoeial leaders, regulatory authorities, and industry stakeholders to deliberate on key issues related to pharmaceutical standards and harmonization.

Addressing the gathering, Patel reaffirmed India's commitment to global pharmaceutical standardization and regulatory convergence. She highlighted India's role as the "Pharmacy of the World" and emphasized the importance of ensuring access to high-quality medicines globally. She stated that the IMWP serves as a vital platform to foster international collaboration in pharmacopoeial science and regulatory harmonization.

On this occasion, the Union Minister also released the IPC Newsletter 2024 and a special IPC video film, which showcase India's advancements in pharmacopoeial science and the Commission's efforts in ensuring high-quality pharmaceutical standards. The video film can be accessed at the following link: https://www.youtube.com/watch?v=MCdAZodvOSM .

Punya Salila Srivastava, Secretary, Ministry of Health and Family Welfare, underscored the significance of global partnerships in strengthening pharmaceutical quality standards. She reiterated India's efforts in aligning regulatory frameworks with international best practices and ensuring the availability of safe and effective medicines worldwide.

Dr. Rajeev Singh Raghuvanshi, Secretary-cum-Scientific Director, IPC, and Drugs Controller General (India), highlighted IPC's contributions in setting global benchmarks in pharmacopoeial science. He elaborated on IPC's initiatives, including the IP Online platform, which enhances accessibility and usability of Indian Pharmacopoeia standards. He emphasized the role of scientific advancements and regulatory cooperation in shaping global pharmaceutical standards.

Dr. Roderico H. Ofrin, WHO Representative to India, commended India's leadership in pharmacopoeial standard-setting and emphasized the importance of regulatory harmonization in ensuring patient safety and public health.

The 15th IMWP is set to facilitate discussions on key focus areas, including:

- Updates on recommendations from the 14th IMWP and review of progress on harmonization initiatives.

- Emerging issues in impurity assessment (Q3) and the implications of ICH Q6 guidelines on pharmacopoeial monograph specifications.

- Defining the IMWP Charter to establish a long-term governance structure for the forum.

- Enhancing collaboration among global pharmacopoeias and regulatory bodies, with updates from the Pharmacopoeial Discussion Group (PDG).

- Promotion of environmental sustainability in pharmacopoeial practices and pharmaceutical manufacturing standards.

- Finalization of reports for the 15th IMWP and preparatory discussions for the 16th IMWP.

The deliberations during the IMWP will reinforce the role of pharmacopoeias in ensuring the quality, safety, and efficacy of medicines. The outcomes of the meeting will guide future collaborations in standard-setting and regulatory harmonization.

The 15th IMWP, which commenced today, will conclude on 7th February 2025. The discussions held over these three days will set the stage for further strengthening global pharmacopoeial cooperation and enhancing pharmaceutical quality assurance.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.